Highlights the need for further research into interventions that can modify cardiac ageing processes, a major risk factor for cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Clinicians should await validation before using cardiac ageing interventions; leaves open key research gaps in cardiovascular prevention.
The share of elderly people in the general population has been steadily increasing. Age is one of the main risk factors (RFs) of cardiovascular disease. However, the current focus of preventive medicine is on modifiable RFs, such as arterial hypertension, hypercholesterolemia, and smoking, while age is regarded as a nonmodifiable, non-correctable RF. This emphasises the importance of the identification of cardiac ageing mechanisms and potential modifying interventions. All the existing methods which target cardiac ageing processes have not been used in the clinical settings and require further research. The key intervention methods are described in the paper.
No takes yet. Share an insight, caveat, or question.
Акашева et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: